Filer Snapshot

Veradermics, Inc SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001827635.

Entity Type

Company

Total Filings

50

Latest Filing

30 Mar 2026

Industry

Pharmaceutical Preparations

Save or continue research

Save this filer for return loops, then jump into the latest filing evidence.

Save this research page

Create a free account to save this filer and follow future SEC filing updates.

Review latest filings on this page Open insider trading context
Symbol
MANE on NYSE
Business address
470 James Street, New Haven, CT, 06513
State of incorporation
DE
Fiscal year end
31 December

Sponsored

Quick Takeaways

  • Veradermics, Inc is an SEC filer tracked under CIK 0001827635.
  • 50 filings are listed on this profile.
  • Common form coverage includes 10-K, 8-K, 4/A and more.

What Changed

  • Latest filing: 10-K filed on 30 Mar 2026.
  • Report period: 31 Dec 2025.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Official SEC Source

Official SEC Source

SEC EDGAR submissions for CIK 0001827635.

See Original Filing

Filer Overview

Veradermics, Inc has filed 50 SEC EDGAR filings since 09 Oct 2020. Common forms include 10-K, 8-K, 4/A, SCHEDULE 13D and more.

Latest Filings

Recent SEC filings for Veradermics, Inc with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 30 Mar 2026 31 Dec 2025 001-43097
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 30 Mar 2026 30 Mar 2026 001-43097
4/A Open 4/A document View SEC filing for 4/A FORM 4/A 27 Feb 2026 03 Feb 2026
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 12 Feb 2026 005-95484
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 12 Feb 2026 005-95484
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 11 Feb 2026 005-95484
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 11 Feb 2026 005-95484
4 Open 4 document View SEC filing for 4 09 Feb 2026 04 Feb 2026
3 Open 3 document View SEC filing for 3 09 Feb 2026 04 Feb 2026
4 Open 4 document View SEC filing for 4 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
4 Open 4 document View SEC filing for 4 FORM 4 05 Feb 2026 03 Feb 2026
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 05 Feb 2026 333-293238
8-K Open 8-K document View SEC filing for 8-K 8-K 05 Feb 2026 05 Feb 2026 001-43097
424B4 Open 424B4 document View SEC filing for 424B4 424B4 04 Feb 2026 333-292657
CERT Open CERT document View SEC filing for CERT NYSE CERTIFICATION 04 Feb 2026 001-43097
3 Open 3 document View SEC filing for 3 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
3 Open 3 document View SEC filing for 3 FORM 3 03 Feb 2026 03 Feb 2026
S-1MEF Open S-1MEF document | Open XBRL data View SEC filing for S-1MEF S-1MEF 03 Feb 2026 333-293180
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 03 Feb 2026 001-43097
FWP Open FWP document View SEC filing for FWP FWP 03 Feb 2026 333-292657
EFFECT Open EFFECT document View SEC filing for EFFECT 30 Jan 2026 333-292657
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1/A 28 Jan 2026 333-292657
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 09 Jan 2026 333-292657
D Open D document View SEC filing for D 28 Oct 2025 021-562294
DRS Open DRS document View SEC filing for DRS 27 Oct 2025 377-08614
D Open D document View SEC filing for D 10 Dec 2024 021-531652
D Open D document View SEC filing for D 01 May 2023 021-480424
D/A Open D/A document View SEC filing for D/A 07 Oct 2021 021-415905
D Open D document View SEC filing for D 06 Oct 2021 021-415905
D Open D document View SEC filing for D 09 Oct 2020 021-377538

About this filer

Veradermics, Inc files with the SEC under CIK 0001827635. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.